FacebookLinkedinTwitter

Resources

/Resources
Resources 2021-04-28T14:16:20-04:00

RESOURCES

Browse our Resources

Use the below filters and search to find publications including Amicus Briefs, Testimony and Comments, IPO Law Journal Articles, and the IPO Federal Circuit Summaries™.

TITLE PUBLISHED CATEGORY
IPO Comments to USPTO on Future Strategies for Anticounterfeiting and Piracy September 25, 2023 Testimony and Comments
USPTO OBVIOUSNESS DECISION WAS SUPPORTED BY SUBSTANTIAL EVIDENCE* Elekta Ltd. v. ZAP Surgical Systems, Inc., 21-1985 September 21, 2023 IPO Federal Circuit Summaries
IPO Comments Regarding India’s “Draft Patents (Amendment), Rules, 2023.” September 20, 2023 Testimony and Comments
ANTIBODY CLAIMS INVALID FOR LACK OF ENABLEMENT* * Baxalta Inc. v. Genentech, Inc., 22-1461 September 20, 2023 IPO Federal Circuit Summaries
PRIOR-ART DESIGN MUST BE APPLIED TO SAME ARTICLE OF MANUFACTURE TO QUALIFY AS COMPARISON PRIOR ART IN INFRINGEMENT ANALYSIS* * * Columbia Sportswear North America, Inc. v. Seirus Innovative Accessories, Inc., 21-2299 September 15, 2023 IPO Federal Circuit Summaries
IPR DECISIONS VACATED ON BASIS OF APA VIOLATION AND ERRONEOUS CLAIM CONSTRUCTION* Apple Inc. v. Corephotonics, Ltd., 22-1350 September 11, 2023 IPO Federal Circuit Summaries
FIELD OF ENDEAVOR FINDING IN IPR VACATED* Netflix, Inc. v. DivX, LLC, 22-1138 September 11, 2023 IPO Federal Circuit Summaries
COURT UPHOLDS IPR DECISIONS CANCELING CELL PHONE CONNECTION CLAIMS* Sisvel International S.A. v. Sierra Wireless, Inc., 22-1387 September 01, 2023 IPO Federal Circuit Summaries
IPO Comments to European Patent Office Regarding User Consultation on the Proposed Amendments to the Rules of Procedure of the Boards of Appeal August 31, 2023 Testimony and Comments
***Expiration Date for Obviousness-Type Double Patenting Analysis on Patent with PTA is Expiration Date After PTA Added* August 29, 2023 IPO Federal Circuit Summaries
USPTO ERRED IN ANALYZING OBJECTIVE INDICIA OF NONOBVIOUSNESS* * Volvo Penta of the Americas, LLC v. Brunswick Corporation, 22-1765 August 24, 2023 IPO Federal Circuit Summaries
COURT UPHOLDS IPR DECISIONS CANCELING CLAIMS AS UNPATENTABLE* Incept LLC v. Palette Life Sciences, Inc., 21-2063 August 16, 2023 IPO Federal Circuit Summaries
IPO Comments to USPTO Regarding Proposed Design Patent Practitioner Bar August 14, 2023 Testimony and Comments
REPLY ARGUMENTS IN IPR DID NOT CONSTITUTE NEW THEORIES* Rembrandt Diagnostics, LP v. Alere, Inc., 2021-1796 August 11, 2023 IPO Federal Circuit Summaries
USPTO MUST ALLOW PETITIONER TO PRESENT ARGUMENT AND EVIDENCE UNDER CLAIM CONSTRUCTION PROPOSED BY PATENT OWNER AFTER INSTITUTION DECISION* * Axonics, Inc. v. Medtronic, Inc., 22-1532 August 07, 2023 IPO Federal Circuit Summaries
IPO Comments to European Commission On EU Compulsory Licensing Proposal July 31, 2023 Testimony and Comments
IPO Comments to USPTO Regarding Motion To Amend Pilot Program and Rules of Practice To Allocate the Burdens of Persuasion on Motions To Amend in Trial Proceedings Before the PTAB July 24, 2023 Testimony and Comments
METHOD OF TREATMENT CLAIMS WERE NOT INVALID FOR LACK OF ENABLEMENT OR WRITTEN DESCRIPTION* * United Therapeutics Corp. v. Liquidia Technologies, Inc., 22-2217 July 24, 2023 IPO Federal Circuit Summaries
Resolution Related to Anti-Suit Injunctions July 20, 2023 Board Resolutions
Resolution Related to USPTO-FDA Collaboration July 20, 2023 Board Resolutions
IPOwners Quarterly™ 7/17/2023 July 17, 2023 IPOwners Quarterly
PATENT WAS DIRECTED TO PATENT-INELIGIBLE ABSTRACT IDEA* * Trinity Info Media, LLC v. Covalent, Inc., 22-1308 July 14, 2023 IPO Federal Circuit Summaries
PURE AIA PATENTS MAY NOT BE SUBJECTED TO INTERFERENCE PROCEEDINGS* * SNIPR Technologies Limited v. Rockefeller University, 22-1260 July 14, 2023 IPO Federal Circuit Summaries
REISSUE CLAIMS INVALID FOR FAILING TO COMPLY WITH “ORIGINAL PATENT” REQUIREMENT* * In re Float‘N’Grill LLC, 22-1438 July 12, 2023 IPO Federal Circuit Summaries
FEDERAL CIRCUIT VACATES IPR DECISION BASED ON ERRONEOUS MOTIVATION TO COMBINE ANALYSIS* * Axonics, Inc. v. Medtronic, Inc., 22-1451 July 10, 2023 IPO Federal Circuit Summaries
2022-2023 Impact Report July 05, 2023 IPO Law Journal
INDUCED INFRINGEMENT SUIT WAS NOT PRECLUDED BY EARLIER DIRECT INFRINGEMENT JUDGMENT* * Inguran, LLC v. ABS Global, Inc., 22-1385 July 05, 2023 IPO Federal Circuit Summaries
FEDERAL CIRCUIT GRANTS EN BANC REHEARING ON APPLICABILITY OF KSR TO DESIGN PATENTS* * LKQ Corp. v. GM Global Technology Operations LLC, 21-2348 June 30, 2023 IPO Federal Circuit Summaries
FEDERAL CIRCUIT REJECTS APA CHALLENGE TO USPTO MOTION TO AMEND PILOT PROGRAM* * Medytox, Inc. v. Galderma S.A., 22-1165 June 27, 2023 IPO Federal Circuit Summaries
USPTO ERRED IN ANALYZING LIKELIHOOD OF CONFUSION* * Spireon, Inc. v. Flex LTD., 22-1578 June 26, 2023 IPO Federal Circuit Summaries
IPO Comments to USPTO Regarding Advance Notice of Proposed Rulemaking on PTAB Discretionary Institution Practices June 20, 2023 Testimony and Comments
USPTO CORRECTLY REJECTED PATENT CLAIMS AS OBVIOUS* In re Couvaras, 22-1489 June 14, 2023 IPO Federal Circuit Summaries
IPO Comments Regarding USPTO Proposed Trademark Fee Schedule June 12, 2023 Testimony and Comments
COURT UPHOLDS IPR DECISION CANCELING CLAIMS WHERE PATENT OWNER IMPERMISSIBLY INCORPORATED EVIDENCE BY REFERENCE* Parus Holdings, Inc. v. Google LLC, 22-1269 June 12, 2023 IPO Federal Circuit Summaries
FEDERAL CIRCUIT AFFIRMS DECISION ADDING CO-INVENTOR TO EXPANDABLE HOSE CLAIMS* June 09, 2023 IPO Federal Circuit Summaries
COURT OVERTURNS IPR DECISION PREMISED ON ERRONEOUS CONSIDERATION OF SECONDARY-CONSIDERATION EVIDENCE* Yita LLC v. MacNeil IP LLC, 22-1373 June 06, 2023 IPO Federal Circuit Summaries
IPR PETITIONER DID NOT PROVE UNPATENTABILITY OF GUIDE CATHETER CLAIMS* * Medtronic, Inc. v. Teleflex Innovations S.A.R.L., 21-2359 June 05, 2023 IPO Federal Circuit Summaries
COURT UPHOLDS FINDING THAT IPR PETITIONER DID NOT PROVE UNPATENTABILITY OF GUIDE CATHETER CLAIMS* * Medtronic, Inc. v. Teleflex Innovations S.A.R.L., 21-2357 June 05, 2023 IPO Federal Circuit Summaries
IPO Comments to Patent Public Advisory Committee re: USPTO Proposed Patent Fee Adjustments May 25, 2023 Testimony and Comments
USPTO CORRECTLY DETERMINED THAT PATENT WAS NOT PRIOR ART TO CHALLENGED CLAIMS* Medtronic, Inc. v. Teleflex Innovations S.À.R.L., 21-2356 May 24, 2023 IPO Federal Circuit Summaries
Load More